ModelEdge
Oyster Point Pharma Inc.
0001720725
Filing type
8-K
Filing date
Jan 2, 2023
Updated
Jan 3, 2023 ยท 2:12 AM

Filing

8-KEnd of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws

Exhibits

EX-3.1EX-3.1EX-3.2EX-3.2